Body

First & Only FDA-approved TNF inhibitor for non-radiographic axial spondyloarthritis (nr-axSpA)

 
For nr-axSpA patients

CIMZIA® (certolizumab pegol) is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis
(nr-axSpA) with objective signs of inflammation.

NEXT: Learn the Facts About nr-axSpA
NR axSpA